Results 81 to 90 of about 204,314 (304)

The association between eczema, asthma and rhinitis -population studies of prevalence and risk factors among adults [PDF]

open access: yes, 2016
Background: Allergic diseases such as asthma, rhinitis and eczema have increased significantly since the middle of the past century and are now common conditions among both children and adults.
Rönmark, Erik P
core  

Successful Lebrikizumab Therapy in Two Patients With Atopic Dermatitis Resistant to Multiple Therapies

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT The treatment landscape for moderate‐to‐severe atopic dermatitis (AD) has evolved significantly with the introduction of novel targeted therapies addressing specific pathogenic mechanisms of the disease. Despite this therapeutic revolution, a proportion of patients experience intolerance and/or inadequate response to multiple lines of ...
Elena Ippoliti   +5 more
wiley   +1 more source

Analysis of heritability and environmental factors in preschool children with eczema: a case-control study

open access: yesScientific Reports
Eczema is common in children, and its onset is affected by both genetic and environmental factors. We investigated the effects of genetic and environmental factors on the incidence of eczema in preschool children.
Qingfang Du   +5 more
doaj   +1 more source

Allergic Contact Dermatitis: A Comparative Study of Elderly and Young Over Time

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Delayed hypersensitivity reactions, such as allergic contact dermatitis (ACD), present distinct patterns across age groups. While age‐related immune changes are well‐documented, their impact on patch test outcomes and allergen sensitization in elderly individuals remains underexplored.
Roberto Mazzetto   +5 more
wiley   +1 more source

Patients’ and Caregivers’ Experiences Navigating the Burden of Atopic Dermatitis in Argentina

open access: yesMedicina
Background and Objectives: Little is known about patients’ and caregivers’ experiences with atopic dermatitis (AD) in Argentina, so a survey was administered to learn more.
Korey Capozza   +4 more
doaj   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare—A Survey-Based Patient Experience

open access: yesJournal of Patient Experience
Atopic dermatitis (AD) is a chronic and fluctuating disease. Optimal management of AD and related comorbidities requires seamless coordination across multiple layers of the healthcare system.
Thrasyvoulos Tzellos   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy